Project Grant R21EY035371
Award Date
9/30/23
Completion Date
8/31/25
Dollars Obligated
$443K
Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90089, USA
Similar Awards
This Cooperative Agreement award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) provides $998,356 to Revive Biotechnology Inc. to develop an oxygen nanobubble platform technology for treating ischemic retinal diseases. The project aims to secure an Investigational New Drug (IND) indication for the treatment of central retinal artery occlusion (CRAO), a leading cause of sudden vision loss, and then expand the technology to...
This Project Grant award from the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867) will fund the development of a new wide-field visible-light optical coherence tomography (WF-VIS-OCT) device to evaluate the oxygen-induced retinopathy (OIR) model in rats. The $623,090 award, effective September 1, 2024, will support the Oregon Health & Science University in three main efforts: 1) developing the WF-VIS-OCT system with 5-mm transverse resolution over a...
The University of Southern California (USC) received a $480,140 Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) to develop new treatment strategies for diabetic retinopathy (DR). The key objectives are to: 1) evaluate the targeted delivery of therapeutic extracellular vesicles (exosomes) to areas of retinal vascular dysfunction in DR, and 2) determine if Müller glia-derived exosomes can protect the retinal neurovascular unit and mitigate DR...
The U.S. National Eye Institute (NEI) awarded a $184,117 Project Grant (CFDA 93.867 - Vision Research) to Oakland University to determine the role of G-coupled protein receptors GPR31 and GPR39 in the pathogenesis of diabetic retinopathy. The project aims to investigate the affinities and substrate specificities of GPR31 and GPR39 for 12- and 15-HETE metabolites in retinal endothelial cells and Müller cells under normal and hyperglycemic conditions. It will also examine the effects of GPR31 or...
This Project Grant award of $400,000.00 from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports research to investigate the ontology and function of retinal perivascular macrophages during neuroinflammation. The research aims to determine the origin and longevity of these macrophages, as well as their role in experimental autoimmune uveitis and diabetic retinopathy. This work will advance the understanding of the blood-retina barrier and its disruption in...
This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) for $113,274 aims to develop innovative laser-based surgical techniques for the minimally invasive treatment of vitreoretinal disorders. The key products and services to be delivered include: Characterization of ultrafast, nonthermal laser ablation effects on ex vivo vitreous and retinal tissues, and the development of an integrated optical coherence tomography (OCT)-laser system. Development of 3D...
The National Eye Institute (NEI) awarded a $624,230 Project Grant (CFDA 93.867 - Vision Research) to the University of California, Los Angeles (UCLA) with a performance period from May 1, 2025 to April 30, 2029. The grant supports research to investigate the physiology and adaptive mechanisms of the degenerating retina, focusing on understanding how rod photoreceptors and their connections to bipolar cells are affected as retinal degeneration progresses. Key objectives include documenting...
The National Eye Institute (NEI) awarded a $410,000 federal Project Grant under the Vision Research program (CFDA 93.867) to The University of Texas Southwestern Medical Center to study the molecular mechanisms of Wnt signaling in the development and maintenance of the blood-retina barrier and blood-brain barrier. The research aims to unravel the precise role of the Wnt signaling ligands Norrin and Wnt7, and their co-receptors, in regulating vascular development and barrier function in the...
The National Eye Institute (NEI) awarded a Project Grant (CFDA 93.867 - Vision Research) totaling $1,298,882.00 to the University of Oklahoma Health Sciences Center to investigate extracellular microRNA-mediated communication between retinal pigment epithelium (RPE) and microglia. The primary goals are to study the transfer of extracellular microRNAs between these two cell types and evaluate the use of engineered RPE-derived extracellular vesicles as a strategy to mitigate retinal inflammation...
This $475,442 federal Project Grant award from the National Eye Institute (NEI) Vision Research program (CFDA 93.867) supports research on the mechanisms underlying the ingestion of photoreceptor outer segment tips by the retinal pigment epithelium (RPE). The proposed studies combine in vitro experiments on primary RPE cells and in vivo analyses to investigate the actin polymerization dynamics involved in this critical cellular process, which is essential for photoreceptor cell viability. The...